Evidence map›Paper›PMID 32922488›Full record

ArticleIranian journal of pharmaceutical research : IJPR2020

Improvement of Ocular Efficacy of Levofloxacin by Bioadhesive Chitosan Coated PLGA Nanoparticles: Box-behnken Design,

Ameeduzzafar, Nazia Khan, Nabil K Alruwaili, Syed Nasir Abbas Bukhari, Bader Alsuwayt, Muhammad Afzal, Sana Akhter, Mohd Yasir, Mohammed Elmowafy, Khaled Shalaby and 1 more

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

AmeeduzzafarDepartment of Pharmaceutics, College of Pharmacy, Jouf University, Skaka, P.O. Box 2014, Saudi Arabia.
Nazia KhanDepartment of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
Nabil K AlruwailiDepartment of Pharmaceutics, College of Pharmacy, Jouf University, Skaka, P.O. Box 2014, Saudi Arabia.
Syed Nasir Abbas BukhariDepartment of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Skaka, P.O. Box 2014, Saudi Arabia.
Bader AlsuwaytDepartment of Pharmaceutics, Faculty of Pharmacy, Northern Border University, KSA.
Muhammad AfzalDepartment of Pharmacology, College of Pharmacy, Jouf University, Skaka, P.O. Box 2014, Saudi Arabia.
Sana AkhterDepartment of Pharmacology, College of Pharmacy, Jouf University, Skaka, P.O. Box 2014, Saudi Arabia.
Mohd YasirDepartment of Pharmacy, College of Health Science, Arsi University, Asella, Ethopia.
Mohammed ElmowafyDepartment of Pharmaceutics, College of Pharmacy, Jouf University, Skaka, P.O. Box 2014, Saudi Arabia.
Khaled ShalabyDepartment of Pharmaceutics, College of Pharmacy, Jouf University, Skaka, P.O. Box 2014, Saudi Arabia.
Asgar AliDepartment of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
Al Jouf University · SAJamia Hamdard · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conjunctivitis is considered as a common infection of ocular surfaces. Eye drop is most commonly used for treatment of conjunctivitis, but has some drawback like 95% drug eliminated after administration. Administration of levofloxacin to the anterior site in form of chitosan coated poly (lactic-co-glycolic acid) nanoparticles (LFV-CS-PLGA-NPs) expected to overcome these problem and increasing corneal contact time and permeability for effective treatment of bacterial conjunctivitis. The Nanoparticles were developed by single emulsion solvent evaporation technique and optimized for different variables (chitosan, poly (lactide-co-glycolic acid) and polyvinyl alcohol concentration) by employing three factors, three levels Box-Behnken statistical design. The nanoparticles were evaluated for particle size, drug loading, entrapment efficiency, drug release,

Indexed as

Box-BehnkenConfocal microscopy antimicrobial studyGamma scintigraphyLevofloxacin loaded coated PLGA nanoparticlesOcular irritation

Identifiers

PMID32922488
PMCPMC7462482
OpenAlexW3015162669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.